All Stories

  1. LYNX-1: A Phase 3 Study of 0.75% Phentolamine Ophthalmic Solution in Subjects With Dim Light Vision Disturbances
  2. A Nerve-Dependent NGF Receptor Switch Controls Corneal Epithelial Renewal In Neurotrophic Keratopathy
  3. Assessing ocular dominance: rethinking the current paradigm
  4. Reversal of Pharmacologically Induced Mydriasis with Phentolamine Ophthalmic Solution
  5. Neurotrophic keratopathy: An updated understanding
  6. A randomized phase 2 clinical trial of phentolamine mesylate eye drops in patients with severe night vision disturbances
  7. Expert consensus on the identification, diagnosis, and treatment of neurotrophic keratopathy
  8. Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial
  9. Phentolamine Mesylate Ophthalmic Solution Provides Lasting Pupil Modulation and Improves Near Visual Acuity in Presbyopic Glaucoma Patients in a Randomized Phase 2b Clinical Trial
  10. <p>Objective Quantification of Image Quality and Optical Scatter Before and After Nd:YAG Capsulotomy Using a Double-Pass Technique</p>
  11. Perspective on Systematic Medical Literature Reviews and Meta-Analyses
  12. <p>Direct and Indirect Costs of Infectious Conjunctivitis in a Commercially Insured Population in the United States</p>
  13. ISOPT Clinical Hot Topic Panel Discussion on Cornea Anterior Segment Disease
  14. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis
  15. A randomized controlled trial of povidone-iodine/dexamethasone ophthalmic suspension for acute viral conjunctivitis
  16. Longitudinal changes in dry eye symptoms and signs following lifitegrast therapy and relationship to tear osmolarity
  17. Reply
  18. Randomized, Controlled, Phase 2 Trial of Povidone-Iodine/Dexamethasone Ophthalmic Suspension for Treatment of Adenoviral Conjunctivitis
  19. Evaluation of the small-aperture intracorneal inlay: Three-year results from the cohort of the U.S. Food and Drug Administration clinical trial
  20. Long-term safety follow-up of an anterior chamber angle-supported phakic intraocular lens
  21. TFOS DEWS II iatrogenic report
  22. Accommodating Intraocular Lenses
  23. Benefits and barriers of accommodating intraocular lenses
  24. Contrast Sensitivity in Patients With Emmetropic Presbyopia Before and After Small-Aperture Inlay Implantation
  25. Reply
  26. Reply
  27. Progressively Increased Variation in Tear Osmolarity Mirrors Dry Eye Severity
  28. Comparison of Contrast Sensitivity and Through Focus in Small-Aperture Inlay, Accommodating Intraocular Lens, or Multifocal Intraocular Lens Subjects
  29. Safety and effectiveness of a new toric presbyopia-correcting posterior chamber silicone intraocular lens
  30. A Prospective Randomized Clinical Evaluation of 3 Presbyopia-Correcting Intraocular Lenses After Cataract Extraction
  31. Rethinking Dry Eye Disease: A Perspective on Clinical Implications
  32. The Value of Tear Osmolarity as a Metric in Evaluating the Response to Dry Eye Therapy in the Clinic and in Clinical Trials
  33. Corneal inlays for presbyopia correction
  34. Comparing visual function of accommodating IOLs versus mini-monovision with a nonaccommodating monofocal IOL
  35. Evaluation of Tear Osmolarity in Non-Sjögren and Sjögren Syndrome Dry Eye Patients With the TearLab System
  36. Acute Retinal Necrosis Syndrome
  37. Small-aperture contact lenses for presbyopia
  38. Clinical Utility of Objective Tests for Dry Eye Disease
  39. Comparison of Through-Focus Image Sharpness Across Five Presbyopia-Correcting Intraocular Lenses
  40. Tear Osmolarity in the Diagnosis and Management of Dry Eye Disease
  41. March consultation #4
  42. An Objective Approach to Dry Eye Disease Severity
  43. Comparing pupil-dependent image quality across presbyopia-correcting intraocular lenses
  44. February consultation #10
  45. Postoperative changes in intraocular pressure and corneal biomechanical metrics
  46. Novel Objective Method for Comparing Ablation Centration With and Without Pupil Tracking Following Myopic Laser In Situ Keratomileusis Using the Bausch & Lomb Technolas 217A
  47. Comparison of contrast sensitivity, depth of field and ocular wavefront aberrations in eyes with an IOL with zero versus positive spherical aberration
  48. Maximizing Satisfaction with Presbyopia-Correcting Intraocular Lenses: The Missing Links
  49. Biometry and intraocular lens power calculation
  50. Visual Performance of Patients with Bilateral vs Combination Crystalens, ReZoom, and ReSTOR Intraocular Lens Implants
  51. Comparative performance of the Zyoptix XP and Hansatome zero-compression microkeratomes
  52. Reply: Determining corneal power using Orbscan II videokeratography for IOL calculation after excimer laser surgery for myopia
  53. Determining corneal power using Orbscan II videokeratography for intraocular lens calculation after excimer laser surgery for myopia
  54. Changes in Corneal Biomechanics and Intraocular Pressure Following LASIK Using Static, Dynamic, and Noncontact Tonometry
  55. Development of late-onset subepithelial corneal haze after laser-assisted subepithelial keratectomy with prophylactic intraoperative mitomycin-C
  56. Ocular Herpes Simplex: Changing Epidemiology, Emerging Disease Patterns, and the Potential of Vaccine Prevention and Therapy
  57. Acute Retinal Necrosis Syndrome
  58. Is There A Role for Neurotrophin Treatment of the Ocular Surface Following Laser In Situ Keratomileusis (LASIK)?
  59. Factors Predictive of LASIK Flap Thickness With the Hansatome Zero Compression Microkeratome
  60. Reply
  61. Subepithelial scarring after laser-assisted subepithelial keratectomy
  62. Optical performance of 3 intraocular lens designs in the presence of decentration
  63. Making sense out of wavefront sensing
  64. Topographic and biomechanical differences between hyperopic and myopic laser in situ keratomileusis
  65. Mitomycin C and Haze
  66. Treatment of dense subepithelial corneal haze after laser-assisted subepithelial keratectomy
  67. The effect of punctal occlusion on wavefront aberrations in dry eye patients after laser in situ keratomileusis
  68. Retained contact lens for more than 10 years in a laser in situ keratomileusis patient
  69. Ocular complications of smallpox vaccination
  70. Intraocular lens calculations in patients with corneal scarring and irregular astigmatism
  71. IMPLANTATION OF SCLERAL EXPANSION BAND SEGMENTS FOR THE TREATMENT OF PRESBYOPIA
  72. Human Corneal Endothelial Cell Expression of Na+, K+–Adenosine Triphosphatase Isoforms
  73. Schachar's Theory of the Mechanisms of Accommodation
  74. Correlation of visual and refractive outcomes between eyes after Same-session bilateral laser in situ keratomileusis surgery
  75. Microdissection combined with the polymerase chain reaction to identify potentiating viral co-infection in patients with HIV/AIDS with ocular infection
  76. Implantation of scleral expansion band segments for the treatment of presbyopia11A complete list of the participants in the Scleral Expansion Band for Presbyopia Study Group can be found at the end of this article.
  77. Therapeutic vaccination with vhs− herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice
  78. Confocal microscopic findings in a case of delayed-onset bilateral diffuse lamellar keratitis after laser in situ keratomileusis
  79. CD4+ and CD8+ cells are key participants in the development of recurrent herpetic stromal keratitis in mice
  80. Therapeutic Immunization with a Virion Host Shutoff-Defective, Replication-Incompetent Herpes Simplex Virus Type 1 Strain Limits Recurrent Herpetic Ocular Infection
  81. InternetAdvance: accelerated internet publication of articles and reports at ajo.com
  82. Astigmatic changes after excimer laser refractive surgery
  83. Comparison of photorefractive keratectomy, astigmatic PRK, laser in situ keratomileusis, and astigmatic LASIK in the treatment of myopia
  84. Management of the corneal flap in laser in situ keratomileusis after previous radial keratotomy
  85. Disinfection of Goldmann tonometers after contamination with hepatitis C virus
  86. Cytokine expression in murine corneas during recurrent herpetic stromal keratitis
  87. Maximizing surgeon safety during excimer laser photorefractive procedures
  88. Editor reply
  89. Repopulation of denuded murine Descemet's membrane with life-extended murine corneal endothelial cells as a model for corneal cell transplantation
  90. CD4+ T CELLS ARE CRITICAL FOR CORNEAL, BUT NOT SKIN, ALLOGRAFT REJECTION1
  91. Stimulation of quiescent corneal endothelial cells by direct delivery of the SV40 large T-antigen protein
  92. Stimulation of quiescent corneal endothelial cells by direct delivery of the SV40 large T-antigen protein
  93. Comparative corneal topography and refractive variables in monozygotic and dizygotic twins
  94. Corneal iron deposits after laser in situ keratomileusis
  95. Discussion
  96. Human cytomegalovirus infection in a retinoblastoma cell line in vitro
  97. Improved impression cytology techniques for the immunopathological diagnosis of superficial viral infections
  98. Neural network computer program to determine photorefractive keratectomy nomograms
  99. Reproduction of antiviral effect in an in vivo model of human cytomegalovirus retinal infection
  100. Screening of Myopic Photorefractive Keratectomy in Eye Bank Eyes by Computerized Videokeratography
  101. CONTROL POINTS REGULATING EPITHELIAL HYPERPLASIA
  102. Efficacy and safety of the proTek (Vifilcon A) therapeutic soft contact lens after photorefractive keratectomy
  103. Effect of PRK on intraocular pressure measurements and on keratometry
  104. Postexposure vaccination with a virion host shutoff defective mutant reduces UV-B radiation-induced ocular herpes simplex virus shedding in mice
  105. Results of Phase III Excimer Laser Photorefractive Keratectomy for Myopia
  106. In Vitro and In Vivo Effects of Polyhexamethylene Biguanide Against Herpes Simplex Virus Infection
  107. An In Vivo Model of Human Cytomegalovirus Retinal Infection
  108. Efficacy of a Recombinant Glycoprotein D Subunit Vaccine on the Development of Primary and Recurrent Ocular Infection with Herpes Simplex Virus Type 1 in Mice
  109. Corneal Topography of Excimer Laser Photorefractive Keratectomy Using a 6-mm Beam Diameter
  110. Future shock: the long term consequences of refractive surgery
  111. Lack of Diurnal Variation in Vision, Refraction, or Keratometry After Excimer Laser Photorefractive Keratectomy
  112. A Critical Evaluation of Hepatitis C Testing of Cadaveric Corneal Donors
  113. SCREENING POTENTIAL CORNEAL DONORS FOR HIV-1 BY POLYMERASE CHAIN REACTION AND A COLORIMETRIC MICROWELL HYBRIDIZATION ASSAY
  114. The Potential Impact of the Varicella Vaccine and New Antivirals on Ocular Disease Related to Varicella-zoster Virus
  115. CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
  116. Retreatment of Decentered Excimer Photorefractive Keratectomy Ablations
  117. Differential effects of HSV-1 and HCMV infection on adhesion molecule expression on human corneal keratocytes
  118. Screening Potential Corneal Donors for HIV-1 by Polymerase Chain Reaction and a Colorimetric Microwell Hybridization Assay
  119. A Comparison of Recurrent and Primary Herpes Simplex Keratitis in NIH Inbred Mice
  120. A UNIQUE CASE OF FUCHS?? SUPERFICIAL MARGINAL KERATITIS: MANAGEMENT VIA CORNEOSCLERAL LAMELLAR PATCH GRAFT
  121. Corneal optical irregularity after excimer laser photorefractive keratectomy
  122. Cystic Hydrops and Spontaneous Perforation in Fuchs' Superficial Marginal Keratitis
  123. Air Bag-related Corneal Rupture After Radial Keratotomy
  124. AIDS-related optic neuropathy: a histological, virological and ultrastructural study
  125. Corneal Topography of Phase III Excimer Laser Photorefractive Keratectomy
  126. Corneal Topography of Phase III Excimer Laser Photorefractive Keratectomy
  127. Topical Interferon Alpha-2A Treatment of Herpes Simplex Keratitis Resistant to Multiple Antiviral Medications in an Immunosuppressed Patient
  128. Anterior Segment Manifestations of Acquired Immunodeficiency Syndrome
  129. AIRBAG-ASSOCIATED CORNEAL RUPTURE TWO YEARS AFTER RADIAL KERATOTOMY
  130. Screening Corneas for Human Immunodeficiency Virus Type 1 Proviral DNA by Polymerase Chain Reaction
  131. Poor Correlation Between Reactive Syphilis Serology and Human Immunodeficiency Virus Testing Among Potential Cornea Donors
  132. ATTITUDES OF SUCCESSFUL CONTACT LENS WEARERS TOWARD REFRACTIVE SURGERY
  133. Sequence changes in the pilus subunit lead to variation of Neisseria gonorrhoeae to human tissue
  134. A structural and functional comparison of the latency-associated transcript promoters of herpes simplex virus type 1 strains KOS and McKrae
  135. Sequence changes in the pilus subunit lead to tropism variation of Neisseria gonorrhoeae to human tissue
  136. The role of nerve growth factor in modulating herpes simplex virus reactivation in vivo
  137. Vaccinia Keratouveitis Manifesting as a Masquerade Syndrome
  138. Spontaneous Resolution of an Extensive Detachment of Descemet's Membrane Following Phacoemulsification
  139. Lack of Evidence for Hepatitis C Virus in Corneas of Seropositive Cadavers
  140. Detection of Cellular Adhesion Molecules in Inflamed Human Corneas
  141. REACTIVE SYPHILIS SEROLOGY IS A POOR MARKER FOR HIV INFECTION AMONG POTENTIAL CORNEAL DONORS IN THE U.S
  142. Comparative Diagnosis of Neonatal Chlamydial Conjunctivitis by Polymerase Chain Reaction and McCoy Cell Culture
  143. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts
  144. Immunocytologic Findings in a Case of Vogt-Koyanagi-Harada Syndrome
  145. The Use of Polymerase Chain Reaction for the Detection of Chlamydial Keratoconjunctivitis
  146. Divergent Approaches to the Management of Corneal Ulcers
  147. Corneal Endothelial Toxicity of DexSol Corneal Storage Medium Supplemented With Povidone-Iodine
  148. Reactivation of Latent Herpes Simplex Virus by Excimer Laser Photokeratectomy
  149. New Developments in Serologic Screening of Corneal Donors for HIV-1 and Hepatitis B Virus Infections
  150. Herpesvirus Antibody Levels in the Etiologic Diagnosis of the Acute Retinal Necrosis Syndrome
  151. Immunopathologic Features of Retinal Lesions in Multiple Sclerosis
  152. Concurrent Chlamydial and Acanthamoeba Keratoconjunctivitis
  153. Screening Corneal Donors for Transmissible Disease
  154. Antimicrobial Efficacy and Corneal Endothelial Toxicity of DexSol Corneal Storage Medium Supplemented with Vancomycin
  155. Herpes simplex keratitis: Role of viral infection versus immune response
  156. Detection of HLA Antigens in Human Epikeratophakia Lenticules
  157. External ocular herpesvirus infections in immunodeficiency
  158. Dual Infection of Retina with Human Immunodeficiency Virus Type 1 and Cytomegalovirus
  159. Mononuclear Cell Phenotypes and Immunoglobulin Gene Rearrangements in Lacrimal Gland Biopsies from Patients with Sjögren's Syndrome
  160. 90122536 Estrogen and progesterone receptors and human conjunctiva
  161. Recurrent Acanthamoeba Keratitis Following Penetrating Keratoplasty
  162. Epidermal Growth Factor in Human Aqueous Humor
  163. Estrogen and Progesterone Receptors and Human Conjunctiva
  164. Sandwich enzyme immunoassay and latex agglutination test for herpes simplex virus keratitis
  165. Epstein-Barr Virus infection and Immunologic Dysfunction in Patients with Aqueous Tear Deficiency
  166. The Sensitivity of Neisseria gonorrhoeae, Chlamydia trachomatis, and Herpes Simplex Type II to Disinfection With Povidone-Iodine
  167. Cellular Immune Response to la Induction by Intraocular Gamma-Interferon
  168. Comparative Laboratory Diagnosis of Experimental Herpes Simplex Keratitis
  169. An Association Between Acute Retinal Necrosis Syndrome and HLA-DQw7 and Phenotype Bw62,DR4
  170. Epidemiology and Diagnosis of Acute Conjunctivitis at an Inner-city Hospital
  171. Congenital Idiopathic Corneal Endotheliopathy
  172. Disinfection of Goldmann Tonometers Against Human Immunodeficiency Virus Type 1
  173. Proliferative Vitreoretinopathy Membranes
  174. Dual Infection of Retina With Human Immunodeficiency Virus Type 1 and Cytomegalovirus
  175. The relationship of corneal Langerhans cells to herpes simplex antigens during dendritic keratitis
  176. The Risk of Cytomegalovirus Transmission by Penetrating Keratoplasty
  177. A viral etiology in Fuchs' corneal dystrophy
  178. Application of Immunologic Technology to the Diagnosis of Viral Infections of the Ocular Surface
  179. Herpes simplex virus Type 1 induces anterior chamber-associated immune deviation (ACAID) in mouse strains resistant to intraocular infection
  180. Serologic Markers After the Transplantation of Corneas from Donors Infected with Human Immunodeficiency Virus
  181. Pathologic Features of Cytomegalovirus Retinopathy after Treatment with the Antiviral Agent Ganciclovir
  182. Screening Cornea Donors for Antibodies Against Human Immunodeficiency Virus
  183. AIDS and Corneal Transplantation
  184. Application of Immunotechnology to the Diagnosis of Ocular Viral Infections
  185. Antiviral sensitivities of the acute retinal necrosis syndrome virus
  186. Class II induction of human corneal fibroblasts by cell-free supernatants from HSV stimulated lymphocytes
  187. Demonstration of Herpes Group Virus in Acute Retinal Necrosis Syndrome
  188. Acute Retinal Necrosis Syndrome Following Herpes Zoster Dermatitis
  189. HTLV-III ELISA testing of cadaveric sera to screen potential organ transplant donors
  190. HTLV-III ELISA Testing of Cadaveric Sera to Screen Potential Organ Transplant Donors
  191. Herpes simplex virus immediate-early protein ICP4 in murine models of latency
  192. Infectious Retinitis
  193. Varicella Zoster Virus is a Cause of the Acute Retinal Necrosis Syndrome
  194. External Diseases
  195. Detection of HLA Class I and II Antigens in Rejected Human Corneal Allografts
  196. The Impact of the AIDS Epidemic on Corneal Transplantation
  197. Acquired Immune Deficiency Syndrome
  198. Immunocytologic Localization of Herpes Simplex Type 1 Viral Antigens in Herpetic Retinitis and Encephalitis in an Adult
  199. Composition of cellular infiltrates in rejected human corneal allografts
  200. Skin Test With Varicella-Zoster Virus Antigen for Ophthalmic Herpes Zoster
  201. Concurrent Herpes Simplex and Cytomegalovirus, Retinitis and Encephalitis in the Acquired Immune Deficiency Syndrome (AIDS)
  202. Retinal Periphlebitis and Retinitis in Multiple Sclerosis
  203. Acquired Immune Deficiency Syndrome
  204. An Analysis of Retinal Cotton-Wool Spots and Cytomegalovirus Retinitis in the Acquired Immunodeficiency Syndrome
  205. A theory of virus-induced demyelination in the Landry-Guillain-Barr� syndrome
  206. Marek's disease: A natural model for the Landry-Guillain-Barr� syndrome
  207. The Humoral Immune Response in Rabbits Infected with Treponema pallidum
  208. Microassay for immunoglobulin G antibodies to Treponema pallidum with radioiodinated protein A from staphylococcus aureus: immunoglobulin G response in experimental syphilis in rabbits
  209. Voltage-sensitive potassium channels in Limulus ventral photoreceptors